| scholarly article | Q13442814 |
| P50 | author | Carlos Fernández-del Castillo | Q40930249 |
| P2093 | author name string | Andrew L Warshaw | |
| Vikram Deshpande | |||
| Gregory Y Lauwers | |||
| Parsia A Vagefi | |||
| Oswaldo Razo | |||
| Sarah P Thayer | |||
| Deborah J McGrath | |||
| P2860 | cites work | Pancreatic endocrine tumors | Q28264318 |
| Laparoscopic enucleation of a nonfunctioning neuroendocrine tumor at the head of the pancreas | Q34467374 | ||
| Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients | Q35494053 | ||
| Surgical treatment of incidentally identified pancreatic masses | Q35537702 | ||
| Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors | Q35757210 | ||
| Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands | Q36331142 | ||
| Pancreatic neuroendocrine tumors: overview of recent advances and diagnosis | Q36452864 | ||
| Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients | Q42659969 | ||
| Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study | Q43481462 | ||
| Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors | Q43851281 | ||
| Resection of pancreatic neuroendocrine tumors: results of 70 cases | Q46079767 | ||
| Dr Dickinson Ober Wheelock--a case of sporadic insulinoma or multiple endocrine neoplasia type 1? | Q50251481 | ||
| Importance of hospital volume in the overall management of pancreatic cancer. | Q50634230 | ||
| Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors. | Q53798319 | ||
| Pancreatic islet cell carcinoma. I. Clinical features of 52 patients | Q68664623 | ||
| Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study | Q72281843 | ||
| Nonfunctioning islet cell tumors | Q72881347 | ||
| Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization | Q73735656 | ||
| Middle segment pancreatectomy: a novel technique for conserving pancreatic tissue | Q74364112 | ||
| Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients | Q77348249 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 347-354 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | Archives of Surgery | Q15764793 |
| P1476 | title | Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005. | |
| P478 | volume | 142 |
| Q35763588 | A Single Centre Analysis of Clinical Characteristics and Treatment of Endocrine Pancreatic Tumours |
| Q37109909 | A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival |
| Q37277977 | Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated? |
| Q43143146 | Cutaneous metastasis as an initial presentation of a non-functioning pancreatic neuroendocrine tumor |
| Q33892438 | Developing a multivariable prognostic model for pancreatic endocrine tumors using the clinical data warehouse resources of a single institution |
| Q37206218 | Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study |
| Q34248466 | ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors |
| Q93087780 | EUS-guided radiofrequency ablation as an alternative to surgery for pancreatic neuroendocrine neoplasms: Who should we treat? |
| Q43104674 | Ectopic spleen and liver hemangioma mimicking metastatic pancreatic neuroendocrine tumor |
| Q37718476 | Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendocrine tumors during parenchymal-sparing pancreatic surgery |
| Q36385139 | Endoscopic ultrasound in gastroenteropancreatic neuroendocrine tumors |
| Q47140426 | Functional and non-functional pancreatic neuroendocrine tumours: ENETS or AJCC TNM staging system? |
| Q58604731 | Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases |
| Q36960581 | Genetics of pancreatic neuroendocrine tumors: implications for the clinic |
| Q57819720 | How should incidental NEN of the pancreas and gastrointestinal tract be followed? |
| Q36701636 | Impact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors |
| Q33388860 | Impact of splenectomy on thrombocytopenia, chemotherapy, and survival in patients with unresectable pancreatic cancer |
| Q36943954 | Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes |
| Q36895820 | Incidentally discovered tumors of the endocrine glands |
| Q35067744 | Intrapancreatic accessory spleen: possibilities of computed tomography in differentiation from nonfunctioning pancreatic neuroendocrine tumor. |
| Q35563155 | Limited surgery for benign tumours of the pancreas: a systematic review |
| Q37373285 | Neuroendocrine neoplasms of liver - A 5-year retrospective clinico-pathological study applying World Health Organization 2010 classification |
| Q38178882 | Neuroendocrine tumors of the pancreas: current concepts and controversies. |
| Q33573118 | Non-functioning pancreatic neuroendocrine tumors: Surgery or observation? |
| Q51023616 | Non-hyperfunctioning pancreatic endocrine tumors: multimodality imaging features with histopathological correlation. |
| Q55313360 | Not only stem cells, but also mature cells, particularly neuroendocrine cells, may develop into tumours: time for a paradigm shift. |
| Q41031563 | Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors |
| Q51119743 | Outcome of surgery for pancreatic neuroendocrine neoplasms. |
| Q41561189 | Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis |
| Q34702075 | Pancreatic fistulae after pancreatic resections for neuroendocrine tumours compared with resections for other lesions |
| Q33720748 | Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT. |
| Q56917284 | Pancreatic neuroendocrine tumors |
| Q44327511 | Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex |
| Q83159840 | Pancreatic neuroendocrine tumors: the impact of surgical resection on survival |
| Q37669053 | Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness |
| Q84842031 | Parenchyma-sparing resections for pancreatic neuroendocrine tumors |
| Q47228887 | Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size |
| Q36558853 | Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review |
| Q51356001 | Preoperative assessment of the pancreas in multiple endocrine neoplasia type 1. |
| Q39018623 | Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration. |
| Q34182397 | Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). |
| Q34503869 | Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT |
| Q83181808 | Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience |
| Q38198509 | Surgical management of pancreatic neuroendocrine neoplasms |
| Q57820051 | Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases |
| Q36154116 | Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms |
| Q34413108 | T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases |
| Q64230390 | The impact of surgery in metastatic pancreatic neuroendocrine tumors: a competing risk analysis |
| Q93107212 | Time-trend and recurrence analysis of pancreatic neuroendocrine tumors |
| Q42210757 | Transition of a pancreatic neuroendocrine tumor from ghrelinoma to insulinoma: a case report |
| Q37350299 | Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study |
| Q59279673 | Treatment options for PNET liver metastases: a systematic review |
| Q35034000 | Tumor-associated macrophages are a useful biomarker to predict recurrence after surgical resection of nonfunctional pancreatic neuroendocrine tumors |
| Q53220408 | [Neuroendocrine tumors of the duodenum and pancreas. Surgical strategy]. |
| Q79819663 | [Total pancreatectomy: renaissance of a surgical procedure] |
Search more.